Insider Sentiment Summary: Drugs

Demo data is delayed six months. Subscribe today and get current information.  Learn More »
Report Time Period: 
Sentiment Summary

Last 52 Weeks

18-Nov-19 - 15-Nov-20
Buy Ratio:34%

Down

# Net Buyers:87
# Net Sellers:170

Previous 52 Weeks

19-Nov-18 - 17-Nov-19
Buy Ratio:39%
# Net Buyers:112
# Net Sellers:177
Buy Ratio History
Number of Companies Filing
Largest Positive Net Change
CompanyNet Buy AmountChange
Tesaro, Inc.--$3.37B  
Loxo Oncology, Inc.--$570.87M  
Aimmune Therapeutics, Inc.$290.13M$290.42M  
Osiris Therapeutics, Inc.--$281.65M  
Spark Therapeutics, Inc.--$256.00M  
New Net Buyers
CompanyNet Buy AmountChange
Aimmune Therapeutics, Inc.$290.13M$290.42M  
Vertex Pharmaceuticals Inc / Ma$6.05M$116.93M  
Alexion Pharmaceuticals, Inc.$33.44M$77.65M  
Charles River Laboratories International, Inc.$477.99K$38.34M  
Fate Therapeutics Inc$24.83M$36.11M  
Largest Negative Net Change
CompanyNet Buy AmountChange
Regeneron Pharmaceuticals, Inc.($1.30B)($1.04B)  
Seagen Inc.($590.80M)($549.72M)  
Corium International, Inc.--($335.08M)  
Eli Lilly & Co($650.13M)($324.52M)  
Vaxart, Inc.($320.48M)($323.10M)  
New Net Sellers
CompanyNet Buy AmountChange
Vaxart, Inc.($320.48M)($323.10M)  
Five Prime Therapeutics, Inc.($144.33M)($154.71M)  
Acadia Pharmaceuticals Inc($9.49M)($63.02M)  
Aerie Pharmaceuticals Inc($18.08M)($37.90M)  
Acceleron Pharma Inc($8.52M)($33.72M)